Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study
Authors
Xiongying Jiang
Song Chen (ORCID: https://orcid.org/0000-0002-2339-3471)
Basic and Applied Basic Research Foundation of Guangdong Province
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study
Xiongying Jiang, Song Chen, Qifeng Chen, Yue Hu et al.
Citations
2 citations
Journal
BMJ Open
Topics
Hepatocellular Carcinoma Treatment and Prognosis
Field-Weighted Citation Impact (FWCI)
2.64
article
Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study
Xiongying Jiang, Song Chen, Qifeng Chen, Yue Hu, Ning Lyu, Ming Zhao
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(5)
Institutions
Sun Yat-sen University (CN), Sun Yat-sen Memorial Hospital (CN), Sun Yat-sen University Cancer Center (CN)
Funders
National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province